These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8313192)

  • 1. [Renal structure and function in experimental diabetic rats following unilateral nephrectomy].
    Liu Z
    Zhonghua Yi Xue Za Zhi; 1993 Sep; 73(9):520-3, 573. PubMed ID: 8313192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat.
    Bach LA; Cooper ME; Vranes D; Allen TJ; Rumble J; Jerums G
    Diabetes Res; 1994; 27(1):27-38. PubMed ID: 7648794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of glomerular filtration and plasma flow in experimental diabetic rats.
    Michels LD; Davidman M; Keane WF
    J Lab Clin Med; 1981 Dec; 98(6):869-85. PubMed ID: 7031154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
    Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
    Samnegård B; Jacobson SH; Johansson BL; Ekberg K; Isaksson B; Wahren J; Sjöquist M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1385-91. PubMed ID: 15004258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and renal characteristics, and responses to acute volume expansion of a rat model of diabetic pregnancy.
    Tang D; Yu T; Khraibi AA
    Life Sci; 2004 Apr; 74(23):2909-18. PubMed ID: 15050428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of unilateral nephrectomy on renal function of diabetic rats.
    Lopes GS; Lemos CC; Mandarim-De-Lacerda CA; Bregman R
    Histol Histopathol; 2004 Oct; 19(4):1085-8. PubMed ID: 15375750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model.
    Palm F; Ortsäter H; Hansell P; Liss P; Carlsson PO
    Diabetes Metab Res Rev; 2004; 20(6):452-9. PubMed ID: 15386825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic glomerulopathy following unilateral nephrectomy in the dog.
    Whiteside C; Katz A; Cho C; Silverman M
    Clin Invest Med; 1990 Oct; 13(5):279-86. PubMed ID: 1703467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
    Vallon V; Albinus M; Blach D
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of excess renal copper on kidney function in the diabetic rat.
    Saunders GK
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):45-9. PubMed ID: 3715196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril and nicardipine on renal hyperfiltration and hypertrophy in uninephrectomized diabetic rats.
    Matsushima Y; Kojima S; Kawamura M; Akabane S; Ito K
    Nihon Jinzo Gakkai Shi; 1988 Mar; 30(3):279-83. PubMed ID: 3050208
    [No Abstract]   [Full Text] [Related]  

  • 13. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal structure and function in streptozotocin-diabetic rats treated with cyclosporin A.
    Thomson KJ; Saunders NJ; Simpson JG; Whiting PH
    Br J Exp Pathol; 1989 Aug; 70(4):405-14. PubMed ID: 2765393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of cardiovascular disorders in streptozotocin-induced diabetes in rat. I. Cardiovascular, renal and morphologic changes in different stages of diabetes.
    Somova L; Dashev G; Doncheva M; Vassileva M
    Acta Physiol Pharmacol Bulg; 1988; 14(3):46-56. PubMed ID: 3066111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
    Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
    Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes.
    Schrijvers BF; De Vriese AS; Van de Voorde J; Rasch R; Lameire NH; Flyvbjerg A
    Nephrol Dial Transplant; 2004 May; 19(5):1092-7. PubMed ID: 14993490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An impairment of barrier size and charge selectivity of glomerular basement membrane in streptozotocin-induced diabetes and prevention by pharmacological therapy.
    Isogai S; Mogami K; Ouchi H; Yoshino G
    Med Electron Microsc; 2000; 33(3):123-9. PubMed ID: 11810469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tight blood pressure control on glomerular hypertrophy in a model of genetic hypertension and experimental diabetes mellitus.
    Amazonas RB; Lopes de Faria JB
    Life Sci; 2006 Oct; 79(22):2135-43. PubMed ID: 16890245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubuloglomerular feedback in renal hypertrophy.
    Pollock CA; Lawrence JR; Field MJ
    Kidney Int Suppl; 1991 Jun; 32():S106-9. PubMed ID: 1881031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.